The clinical spectrum of reversible cerebral vasoconstriction syndrome: The Italian Project on Stroke at Young Age (IPSYS).


Journal

Cephalalgia : an international journal of headache
ISSN: 1468-2982
Titre abrégé: Cephalalgia
Pays: England
ID NLM: 8200710

Informations de publication

Date de publication:
Sep 2019
Historique:
pubmed: 8 5 2019
medline: 27 10 2020
entrez: 8 5 2019
Statut: ppublish

Résumé

To describe clinical, neuroimaging, and laboratory features of a large cohort of Italian patients with reversible cerebral vasoconstriction syndrome. In the setting of the multicenter Italian Project on Stroke at Young Age (IPSYS), we retrospectively enrolled patients with a diagnosis of definite reversible cerebral vasoconstriction syndrome according to the International Classification of Headache Disorders (ICHD)-3 beta criteria (6.7.3 Headache attributed to reversible cerebral vasoconstriction syndrome, imaging-proven). Clinical manifestations, neuroimaging, treatment, and clinical outcomes were evaluated in all patients. Characteristics of reversible cerebral vasoconstriction syndrome without typical causes ("idiopathic reversible cerebral vasoconstriction syndrome") were compared with those of reversible cerebral vasoconstriction syndrome related to putative causative factors ("secondary reversible cerebral vasoconstriction syndrome"). A total of 102 patients (mean age, 47.2 ± 13.9 years; females, 85 [83.3%]) qualified for the analysis. Thunderclap headache at presentation was reported in 69 (67.6%) patients, and it typically recurred in 42 (60.9%). Compared to reversible cerebral vasoconstriction syndrome cases related to putative etiologic conditions (n = 21 [20.6%]), patients with idiopathic reversible cerebral vasoconstriction syndrome (n = 81 [79.4%]) were significantly older (49.2 ± 13.9 vs. 39.5 ± 11.4 years), had more frequently typical thunderclap headache (77.8% vs. 28.6%) and less frequently neurological complications (epileptic seizures, 11.1% vs. 38.1%; cerebral infarction, 6.1% vs. 33.3%), as well as concomitant reversible brain edema (25.9% vs. 47.6%). Clinical manifestations and putative etiologies of reversible cerebral vasoconstriction syndrome in our series are slightly different from those observed in previous cohorts. This variability might be partly related to the coexistence of precipitating conditions with a putative etiologic role on disease occurrence.

Identifiants

pubmed: 31060368
doi: 10.1177/0333102419849013
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1267-1276

Auteurs

Filomena Caria (F)

1 Dipartimento di Scienze Cliniche e Sperimentali, Clinica Neurologica, Università degli Studi di Brescia, Brescia, Italy.

Marialuisa Zedde (M)

2 SC Neurologia, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Massimo Gamba (M)

3 Stroke Unit, Neurologia Vascolare, Spedali Civili di Brescia, Brescia, Italy.

Anna Bersano (A)

4 UO Malattie Cerebrovascolari, Fondazione IRCCS Istituto Neurologico "Carlo Besta", Milan, Italy.

Maurizia Rasura (M)

5 Stroke Unit, Azienda Ospedaliera Sant'Andrea, Università "La Sapienza", Rome, Italy.

Alessandro Adami (A)

6 Stroke Center, Dipartimento di Neurologia, Ospedale Sacro Cuore Negrar, Verona, Italy.

Carlo Piantadosi (C)

7 UOC Neurologia, Azienda Ospedaliera "San Giovanni-Addolorata", Rome, Italy.

Luca Quartuccio (L)

8 Clinica di Reumatologia, Dipartimento di Area Medica, Azienda Ospedaliero-Universitaria "Santa Maria della Misericordia", Udine, Italy.

Cristiano Azzini (C)

9 UO di Neurologia, Dipartimento di Neuroscienze e Riabilitazione, Azienda Ospedaliero-Universitaria di Ferrara, Ferrara, Italy.

Maurizio Melis (M)

10 SC Neurologia and Stroke Unit, Dipartimento Neuroscienze e Riabilitazione, Azienda Ospedaliera "G. Brotzu", Cagliari, Italy.

Maria Luisa Delodovici (M)

11 Unità di Neurologia, Ospedale di Circolo, Università dell'Insubria, Varese, Italy.

Carlo Dallocchio (C)

12 Dipartimento di Area Medica, UOC Neurologia, ASST Pavia, Voghera, Italy.

Carlo Gandolfo (C)

13 Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili, Università di Genova, Genoa, Italy.

Paolo Cerrato (P)

14 Dipartimento di Neuroscienze, Stroke Unit, Università di Torino, Torino, Italy.

Cristina Motto (C)

15 Stroke Unit, Dipartmento di Scienze Neurologiche, Azienda Ospedaliera "Niguarda Ca' Granda", Milan, Italy.

Fabio Melis (F)

16 SS NeuroVascolare Ospedale Maria Vittoria, ASL Città di Torino, Torino, Italy.

Alberto Chiti (A)

17 UO Neurologia, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy.

Mauro Gentile (M)

18 UO Neurologia - Stroke Unit, Ospedale "Santa Maria della Misericordia", Rovigo, Italy.

Valeria Bignamini (V)

19 Stroke Unit, U.O Neurologia, Ospedale "S. Chiara", Trento, Italy.

Andrea Morotti (A)

20 UC Malattie Cerebrovascolari, IRCCS Fondazione Mondino, Pavia, Italy.

Enrico Maria Lotti (E)

21 Unità Operativa Complessa Neurologia, AUSL Romagna, Ravenna, Italy.

Antonella Toriello (A)

22 Unità Operativa Complessa Neurologia, Azienda Ospedaliera Universitaria "San Giovanni di Dio e Ruggi d'Aragona", Salerno, Italy.

Paolo Costa (P)

23 UO Neurologia, Istituto Ospedaliero Poliambulanza, Brescia, Italy.

Giorgio Silvestrelli (G)

24 Stroke Unit, Dipartimento di Neuroscienze, Ospedale Carlo Poma, Mantova, Italy.

Andrea Zini (A)

25 Stroke Unit, Clinica Neurologica, Nuovo Ospedale Civile "S. Agostino Estense", AUSL Modena, Italy.

Valeria De Giuli (V)

1 Dipartimento di Scienze Cliniche e Sperimentali, Clinica Neurologica, Università degli Studi di Brescia, Brescia, Italy.

Loris Poli (L)

1 Dipartimento di Scienze Cliniche e Sperimentali, Clinica Neurologica, Università degli Studi di Brescia, Brescia, Italy.

Maurizio Paciaroni (M)

26 Stroke Unit and Divisione di Medicina Cardiovascolare, Università di Perugia, Italy.

Corrado Lodigiani (C)

27 Centro Trombosi e Malattie Emorragiche, Humanitas Clinical and Research Center, IRCCS, Rozzano-Milano, Italy.

Simona Marcheselli (S)

28 Neurologia d'Urgenza and Stroke Unit, Humanitas Clinical and Research Center, IRCCS, Rozzano-Milano, Italy.

Sandro Sanguigni (S)

29 Dipartmento di Neurologia, Ospedale "Madonna del Soccorso", San Benedetto del Tronto, Italy.

Massimo Del Sette (M)

30 Unità di Neurologia, E.O. Ospedali Galliera, Genova, Italy.

Serena Monaco (S)

31 Stroke Unit, Ospedale Civico, Palermo, Italy.

Piergiorgio Lochner (P)

32 Dipartimento di Neurologia, Saarland University Medical Center, Homburg, Germany.

Carla Zanferrari (C)

33 UOC Neurologia, ASST Melegnano-Martesana, Vizzolo Predabissi, Italy.

Sabrina Anticoli (S)

34 Stroke Unit, Dipartimento di Emergenza-Urgenza, Ospedale "S. Camillo-Forlanini", Rome, Italy.

Alessandro Padovani (A)

1 Dipartimento di Scienze Cliniche e Sperimentali, Clinica Neurologica, Università degli Studi di Brescia, Brescia, Italy.

Alessandro Pezzini (A)

1 Dipartimento di Scienze Cliniche e Sperimentali, Clinica Neurologica, Università degli Studi di Brescia, Brescia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH